This truncating mutation was found in a Chinese woman who developed invasive ductal carcinoma at age 38, which was negative for the expression of the estrogen- and HER-2 receptors and positive for the expression of the progesterone-receptor. Here, PGR is linked to invasive ductal breast carcinoma.